Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism

by Isabel Elías, Itziar Oyagüez, Luis Antonio Alvarez-Sala, Fernando García-Bragadoa, Andrés Navarro, Paloma González, Fernando de Andrés-Nogales, Javier Soto
Published 2016-05-01

Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke

by Kryukov AV, Sychev DA, Andreev DA, Ryzhikova KA, Grishina EA, Ryabova AV, Loskutnikov MA, Smirnov VV, Konova OD, Matsneva IA, Bochkov PO
Published 2018-03-01

Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvement

by Adam Ioannou, Sofia Metaxa, George Kassianos, Constantinos G Missouris
Published 2016-05-01

Assessment of novel oral anticoagulant use within a community teaching hospital

by Sultan Alghadeer, Lori Hornsby
Published 2017-01-01

VENOUS THROMBOEMBOLISM IN CANCER: AN UPDATE OF TREATMENT AND PREVENTION IN THE ERA OF NEWER ANTICOAGULANTS

by Waqas Qureshi, Zeeshan Ali, Zeeshan Ali, Zaid Alirhayim, Waseem Amjad, Hina Farooq, Shayan Qadir, Fatima Khalid, mouaz al-mallah
Published 2016-07-01

New orally active anticoagulants in critical care and anesthesia practice: The good, the bad and the ugly

by Vishal Sehgal, Sukhminder Jit Singh Bajwa, Anurag Bajaj
Published 2013-01-01

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM‐DVT): Methods of a prospective single‐arm management study

by Scott C. Woller, Scott M. Stevens, Stacy A. Johnson, Joseph R. Bledsoe, Brian Galovic, James F. Lloyd, Emily L. Wilson, Brent Armbruster, R. Scott Evans
Published 2019-07-01

Reducing the risk of venous thromboembolism using apixaban – patient perspectives and considerations. Should more attention be given to females?

by Fabbian F, De Giorgi A, Tiseo R, Zucchi B, Manfredini R
Published 2016-01-01

Direct oral anticoagulants and travel-related venous thromboembolism

by Chamnanchanunt Supat, Rojnuckarin Ponlapat
Published 2018-11-01

Off-Label Medicines Use: Complex Problem of Modern Clinical Practice

by S. R. Gilyarevskiy
Published 2020-05-01

Hepatotoxicity of New Oral Anticoagulants

by A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
Published 2018-09-01

Endocarditis trombótica no bacteriana y adenocarcinoma de endometrio

by JORGE CASAL-LORENZO, CÉSAR BARBOLLA-SANCHO, PAULA GARGALLO-FERNANDEZ, MANUEL JESÚS NÚÑEZ-FERNÁNDEZ
Published 2021-04-01

DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples

by Steven Andrew Baker, Jing Jin, Christopher Pfaffroth, Trang Vu, James L. Zehnder
Published 2021-02-01

SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A TWO-YEAR COHORT STUDY

by A. V. Zhilenko, A. A. Sokolova, I. L. Tsarev, D. A. Napalkov
Published 2017-07-01

Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation

by N. Z. Gasymova, E. N. Mikhailov
Published 2019-05-01

GASTROINTESTINAL BLEEDING WITH THE USE OF NEW ORAL ANTICOAGULANTS: EPIDEMIOLOGY, RISK FACTORS, TREATMENT, AND PREVENTION

by E. V. Moroz, A. E. Karateev, E. V. Kryukov, V. A. Chernetsov
Published 2018-01-01

Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventric...

by W Yus Haniff W. Isa, Niny Hwong, Ahmad Khairuddin Mohamed Yusof, Zurkurnai Yusof, Ng Seng Loong, Nadiah Wan-Arfah, Nyi Nyi Naing
Published 2020-01-01

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

by Alexander Cohen, Janvi Sah, Theodore Lee, Lisa Rosenblatt, Patrick Hlavacek, Birol Emir, Allison Keshishian, Huseyin Yuce, Xuemei Luo
Published 2021-01-01

New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

by Mauro Silingardi
Published 2013-12-01

An Exploratory Association Analysis of <i>ABCB</i>₁ rs1045642 and <i>ABCB</i>₁ rs4148738 with Non-Major Bleeding Risk in Atrial Fibrillation Patients Treated...

by Adela-Nicoleta Roşian, Mihaela Iancu, Adrian Pavel Trifa, Ştefan Horia Roşian, Cristina Mada, Cornelia Paula Gocan, Teodora Niţă, Sabina Istratoaie, Paul-Mihai Boarescu, Anca Dana Buzoianu
Published 2020-09-01